Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. IONS
4. ROIV
5. AAPL
6. ACN
7. AZN
8. ORCL
9. HOOD
10. QCOM

Go back to Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026
(NASDAQ: GMAB) Delayed: 33.70 +0.10 (0.30%)
Previous Close $33.60    52 Week High $ 
Open $33.71    52 Week Low $ 
Day High $33.84    P/E N/A 
Day Low $33.36    EPS $ 
Volume 674,507       

(NASDAQ: GMAB) Delayed: 33.70 +0.10 (0.30%)
Previous Close $33.60    52 Week High $ 
Open $33.71    52 Week Low $ 
Day High $33.84    P/E N/A 
Day Low $33.36    EPS $ 
Volume 674,507